AMPK Cancer Research Results
AMPK, adenosine monophosphate-activated protein kinase: Click to Expand ⟱
| Source: |
| Type: |
AMPK: guardian of metabolism and mitochondrial homeostasis; Upon changes in the ATP-to-AMP ratio, AMPK is activated. (AMPK) is a key metabolic sensor that is pivotal for the maintenance of cellular energy homeostasis. It is well documented that AMPK possesses a suppressor role in the context of tumor development and progression by modulating the inflammatory and metabolic pathways.
-Activating AMPK can inhibit anabolic processes and the PI3K/Akt/mTOR pathway reducing glycolysis shifting toward Oxidative Phosphorlylation.
AMPK activators:
-metformin or AICAR
-Resveratrol: activate AMPK indirectly
-Berberine
-Quercetin: may stimulate AMPK
-EGCG: thought to activate AMPK
-Curcumin: may activate AMPK
-Ginsenosides: Some ginsenosides have been associated with AMPK activation
-Beta-Lapachone: A natural naphthoquinone compound found in the bark of Tabebuia avellanedae (also known as lapacho or taheebo). It has been observed to activate AMPK in certain models.
-Alpha-Lipoic Acid (ALA): associated with AMPK activation
|
CRC, Colorectal Cancer: Click to Expand ⟱
Colorectal cancer is a broader term that encompasses both colon and rectal cancer.
|
Scientific Papers found: Click to Expand⟱
| - |
vitro+vivo, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
CRC, |
SW480 |
|
|
|
- |
in-vitro, |
CRC, |
LoVo |
|
|
|
TumVol↓, Ki-67↓, COX2↓, AMPK↑, mTOR↓, NF-kB↓, cycD1/CCND1↓, survivin↓, P53↑, cl‑Casp3↑, TumCP↓, Inflam↓, COX2↓, ACC↑,
| - |
in-vitro, |
CRC, |
T24/HTB-9 |
|
|
|
- |
in-vitro, |
Nor, |
SV-HUC-1 |
|
|
|
- |
in-vitro, |
Bladder, |
5637 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
HDAC↓, AntiTum↑, TumCMig↓, AMPK↑, mTOR↑, TumAuto↑, ROS↑, miR-139-5p↑, BMI1↓, TumCI?, E-cadherin↑, N-cadherin↓, Vim↓, Snail↓, cl‑PARP↑, cl‑Casp3↑, BAX↑, Bcl-2↓, Bcl-xL↓, MMP↓, PINK1↑, PARK2↑, TumMeta↓, TumCG↓, LC3II↑, p62↓, eff↓,
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
CRC, |
HCT8 |
|
|
|
- |
in-vitro, |
CRC, |
SW480 |
|
|
|
- |
in-vitro, |
CRC, |
SW-620 |
|
|
|
p‑AMPK↑, p‑ACC-α↑, NBR2↑, p‑S6K↓, mTOR↓,
| - |
in-vitro, |
Nor, |
MRC-5 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
mTOR↓, AMPK↑, selectivity↑, ROS↑, selectivity↑, HO-1↓, *NRF2↑, NRF2↓, *HO-1↑,
Apoptosis↑, DNAdam↑, Casp3↑, cl‑PARP↑, p‑AMPK↑, Bcl-2↓, P53↑, BAX↑, Cyt‑c↑, TumCMig↓, TumCI↓,
Ferroptosis↑, SIRT3↑, AMPK↑, mTOR↑, tumCV↓, ROS↑, MDA↑, Iron↑,
Glycolysis↓, eff↑, PD-L1↓, AMPK↑, HK2↓, NF-kB↓, Warburg↓, tumCV↓, GLUT1↓, PKM2↓, LDHA↓, CD4+↑, CD8+↑,
Showing Research Papers: 1 to 7 of 7
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 7
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
Ferroptosis↑, 1, HO-1↓, 1, Iron↑, 1, MDA↑, 1, NRF2↓, 1, PARK2↑, 1, ROS↑, 3, SIRT3↑, 1,
Mitochondria & Bioenergetics ⓘ
MMP↓, 1, PINK1↑, 1,
Core Metabolism/Glycolysis ⓘ
ACC↑, 1, p‑ACC-α↑, 1, AMPK↑, 5, p‑AMPK↑, 2, Glycolysis↓, 1, HK2↓, 1, LDHA↓, 1, PKM2↓, 1, p‑S6K↓, 1, Warburg↓, 1,
Cell Death ⓘ
Apoptosis↑, 1, BAX↑, 2, Bcl-2↓, 2, Bcl-xL↓, 1, Casp3↑, 1, cl‑Casp3↑, 2, Cyt‑c↑, 1, Ferroptosis↑, 1, survivin↓, 1,
Transcription & Epigenetics ⓘ
tumCV↓, 2,
Autophagy & Lysosomes ⓘ
LC3II↑, 1, p62↓, 1, TumAuto↑, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 1, NBR2↑, 1, P53↑, 2, cl‑PARP↑, 2,
Cell Cycle & Senescence ⓘ
cycD1/CCND1↓, 1,
Proliferation, Differentiation & Cell State ⓘ
BMI1↓, 1, HDAC↓, 1, mTOR↓, 3, mTOR↑, 2, TumCG↓, 1,
Migration ⓘ
E-cadherin↑, 1, Ki-67↓, 1, miR-139-5p↑, 1, N-cadherin↓, 1, Snail↓, 1, TumCI?, 1, TumCI↓, 1, TumCMig↓, 2, TumCP↓, 1, TumMeta↓, 1, Vim↓, 1,
Barriers & Transport ⓘ
GLUT1↓, 1,
Immune & Inflammatory Signaling ⓘ
CD4+↑, 1, COX2↓, 2, Inflam↓, 1, NF-kB↓, 2, PD-L1↓, 1,
Drug Metabolism & Resistance ⓘ
eff↓, 1, eff↑, 1, selectivity↑, 2,
Clinical Biomarkers ⓘ
Ki-67↓, 1, PD-L1↓, 1,
Functional Outcomes ⓘ
AntiTum↑, 1, TumVol↓, 1,
Infection & Microbiome ⓘ
CD8+↑, 1,
Total Targets: 68
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
HO-1↑, 1, NRF2↑, 1,
Total Targets: 2
Scientific Paper Hit Count for: AMPK, adenosine monophosphate-activated protein kinase
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:6 Cells:% prod#:% Target#:9 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page